Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - December 2012

Oral Solid Dosage Manufacturing Technology (1 day)

14 Dec 2012 - 14 Dec 2012 - Window Conference Venue, 13 Windsor Street, Islington, London, N1 8QG

Bookmark and Share

Oral Solid dosage forms as Tablets and Capsules, are some of the most convenient and most used methods of drug delivery.
This 1-day interactive workshop is intended to provide an understanding of the fundamentals of Oral Solid Dosage manufacture and to highlight the dependency between the various process steps.

Some of the benefits to be derived from this workshop include:

• An understanding of the basics of the Tablet Making Process.
• An appreciation of the demands of the new production environment
• An appreciation of the individual’s role in improving quality at all process stages
• A knowledge of “how things work” and how this may help in trouble shooting & fixing problems

Course Leader:
Mike Cliff is an independent training consultant specialising in the area of oral solid dosage
manufacturing technology. Mike has been a regular presenter at courses and training events
in his 34 year association with the process industries.

Who should attend?
Pharmaceutical facility manufacturing staff and maintenance staff.
Quality Assurance staff, Regulatory staff, Engineering staff, Project Managers and
anybody else involved in operations peripheral to manufacturing who require an
understanding of the basic process operations.

Course Programme

Morning session
• Introduction
• Tablet Formulation
• Impact of Powders Characteristics on Formulation Properties
• Tablet Manufacturing Process
• Dispensing
• Granulation
• Drying
• Dry Milling (Dry Granulation)

Afternoon session
• Blending
• Tablet Compression
• Coating
• Encapsulation
• Warehousing and Quarantine

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos